Nimesulide drug was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presently available in more than 50 countries worldwide with different trademarks.
Osteoarthritis is one of the most common joint disorders. The severity of pain often treated with nonsteroidal anti-inflammatory drug- Nimesulide. Nimesulide has already proved that the Worldwide experience shows nonsteroidal anti-inflammatory drug has a number of pharmacological properties that makes it favorable in the treatment of joint diseases.
Nimesulide is used for the treatment of post-traumatic inflammation, acute musculoskeletal disorders including sprains, strains, tendinitis, tenosynovitis, low back pain, periarthritis (shoulder pain) and osteoarthritis (joint pains), stiffness.
Apart from gastrointestinal safety It also has analgesic and antipyretic properties. Its multifactorial mode of action gives it a unique and broad action on inflammatory process.
Nimesulide brands such as Sulide, Nimalox, Nimesil, Nimulid, Nicip, Nimcap, Nise, Sulidene and Zolan.
It has superior gastrointestinal safety as compared to other NSAIDs.
The maximum duration and dose of a treatment course with Nimesulide medicine is 15 days, 100 mg twice a day, to minimize the risk of hepatotoxicity.
No comments:
Post a Comment